Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01-10-2012 | Article

True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants

Authors: M. Rahkonen, S. Luttinen, M. Koskela, T. Hautala

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2012

Login to get access

Abstract

Our aim was to test whether or not true bloodstream infections (BSI) caused by coagulase negative Staphylococci (CoNS) can be distinguished from blood culture contaminants based on simple clinical and laboratory parameters. Patients with blood cultures positive for CoNS (n = 471) were categorized into community acquired infection (CAI), hospital acquired infection (HAI), infections in patients with haematological conditions (HAEI), or culture contaminants (CON) based on the judgement of a clinician. The cases were further analyzed according to widely accepted criteria for true BSI and whether or not vancomycin treatment was initiated. Simple clinical and laboratory parameters, surgical procedures, mortality, central venous catheters, and other foreign materials were registered. Our study demonstrates that the decision about the significance of positive blood culture finding made by the clinician may differ from that indicated by accepted criteria for BSI. Simple clinical findings such as heart rate, body temperature, or systolic blood pressure may not distinguish a culture contaminant from true infections. In addition, the laboratory parameters were surprisingly similar in the different patient cohorts. A blood culture positive for CoNS remains a clinical challenge; our study demonstrates that judging the significance of the finding is difficult.
Literature
1.
go back to reference Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed
2.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef
3.
go back to reference Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V (2007) Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 51:1320–1326PubMedCrossRef Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V (2007) Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 51:1320–1326PubMedCrossRef
4.
go back to reference von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis 2:677–685CrossRef von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis 2:677–685CrossRef
5.
go back to reference Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed
6.
go back to reference Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMedCrossRef Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMedCrossRef
7.
go back to reference Grace CJ, Lieberman J, Pierce K, Littenberg B (2001) Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 32:1651–1655PubMedCrossRef Grace CJ, Lieberman J, Pierce K, Littenberg B (2001) Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 32:1651–1655PubMedCrossRef
8.
go back to reference Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV (2003) Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41:495–497PubMedCrossRef Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV (2003) Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41:495–497PubMedCrossRef
9.
go back to reference Hautala T, Syrjala H, Lehtinen V, Kauma H, Kauppila J, Kujala P, Pietarinen I, Ylipalosaari P, Koskela M (2005) Blood culture gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents 25:329–333PubMedCrossRef Hautala T, Syrjala H, Lehtinen V, Kauma H, Kauppila J, Kujala P, Pietarinen I, Ylipalosaari P, Koskela M (2005) Blood culture gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents 25:329–333PubMedCrossRef
10.
go back to reference Finkelstein R, Fusman R, Oren I, Kassis I, Hashman N (2002) Clinical and epidemiologic significance of coagulase-negative Staphylococci bacteremia in a tertiary care University Israeli Hospital. Am J Infect Control 30:21–25PubMedCrossRef Finkelstein R, Fusman R, Oren I, Kassis I, Hashman N (2002) Clinical and epidemiologic significance of coagulase-negative Staphylococci bacteremia in a tertiary care University Israeli Hospital. Am J Infect Control 30:21–25PubMedCrossRef
11.
go back to reference Beekmann SE, Diekema DJ, Doern GV (2005) Determining the clinical significance of coagulase-negative Staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26:559–566PubMedCrossRef Beekmann SE, Diekema DJ, Doern GV (2005) Determining the clinical significance of coagulase-negative Staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26:559–566PubMedCrossRef
12.
go back to reference Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D (2005) Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative Staphylococci. Infect Control Hosp Epidemiol 26:697–702PubMedCrossRef Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D (2005) Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative Staphylococci. Infect Control Hosp Epidemiol 26:697–702PubMedCrossRef
13.
go back to reference Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I (2006) Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44:1834–1835PubMedCrossRef Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I (2006) Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44:1834–1835PubMedCrossRef
14.
go back to reference Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I (2009) Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol 47:3255–3260PubMedCrossRef Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I (2009) Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol 47:3255–3260PubMedCrossRef
15.
go back to reference Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef
16.
go back to reference Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:e56–e93PubMedCrossRef Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:e56–e93PubMedCrossRef
17.
go back to reference Plouffe JF Jr, Martin DR (2004) Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infect Dis Clin North Am 18:963–974PubMedCrossRef Plouffe JF Jr, Martin DR (2004) Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infect Dis Clin North Am 18:963–974PubMedCrossRef
18.
go back to reference Somerville GA, Proctor RA (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73:233–248PubMedCrossRef Somerville GA, Proctor RA (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73:233–248PubMedCrossRef
Metadata
Title
True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants
Authors
M. Rahkonen
S. Luttinen
M. Koskela
T. Hautala
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1607-9

Other articles of this Issue 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Go to the issue